Inhibitory synapse deficits caused by familial α1 GABA receptor mutations in epilepsy.

Neurobiol Dis

Queensland Brain Institute, The University of Queensland, Brisbane, Queensland 4072, Australia. Electronic address:

Published: December 2017

AI Article Synopsis

Article Abstract

Epilepsy is a spectrum of neurological disorders with many causal factors. The GABA type-A receptor (GABAR) is a major genetic target for heritable human epilepsies. Here we examine the functional effects of three epilepsy-causing mutations to the α1 subunit (α1, α1 and α1) on inhibitory postsynaptic currents (IPSCs) mediated by the major synaptic GABAR isoform, α1β2γ2L. We employed a neuron - HEK293 cell heterosynapse preparation to record IPSCs mediated by mutant-containing GABARs in isolation from other GABAR isoforms. IPSCs were recorded in the presence of the anticonvulsant drugs, carbamazepine and midazolam, and at elevated temperatures (22, 37 and 40°C) to gain insight into mechanisms of febrile seizures. The mutant subunits were also transfected into cultured cortical neurons to investigate changes in synapse formation and neuronal morphology using fluorescence microscopy. We found that IPSCs mediated by α1β2γ2L, α1β2γ2L GABARs decayed faster than those mediated by α1β2γ2L receptors. IPSCs mediated by α1β2γ2L and α1β2γ2L receptors also exhibited a heightened temperature sensitivity. In addition, the α1β2γ2L GABARs were refractory to modulation by carbamazepine or midazolam. In agreement with previous studies, we found that α1β2γ2L GABARs were retained intracellularly in HEK293 cells and neurons. However, pre-incubation with 100nM suberanilohydroxamic acid (SAHA) induced α1β2γ2L GABARs to mediate IPSCs that were indistinguishable in magnitude and waveform from those mediated by α1β2γ2L receptors. Finally, mutation-specific changes to synaptic bouton size, synapse number and neurite branching were also observed. These results provide new insights into the mechanisms of epileptogenesis of α1 epilepsy mutations and suggest possible leads for improving treatments for patients harbouring these mutations.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.nbd.2017.08.020DOI Listing

Publication Analysis

Top Keywords

ipscs mediated
16
mediated α1β2γ2l
16
α1β2γ2l gabars
16
α1β2γ2l receptors
12
α1β2γ2l
10
α1 α1
8
carbamazepine midazolam
8
α1β2γ2l α1β2γ2l
8
α1
6
ipscs
6

Similar Publications

The differentiation of human induced pluripotent stem cells (hiPSCs) into neural progenitor cells (NPCs) is a promising approach for the treatment of neurodegenerative diseases and regenerative medicine. Dual-SMAD inhibition using small molecules has been identified as a key strategy for directing the differentiation of hiPSCs into NPCs by regulating specific cell signaling pathways. However, conventional culture methods are time-consuming and exhibit low differentiation efficiency in neural differentiation.

View Article and Find Full Text PDF

Protocol for live imaging of axonal transport in iPSC-derived iNeurons.

STAR Protoc

January 2025

Department of Neurology, University Medical Center Goettingen, 37077 Goettingen, Germany. Electronic address:

Studies of human induced pluripotent stem cell (iPSC)-derived neurons promise important insights into neurodegenerative diseases. Here, we present a protocol for live imaging of axonal transport in glutamatergic iPSC-derived neurons (iNeurons). We describe steps for the differentiation of iPSCs into iNeurons via PiggyBac-mediated neurogenin 2 (NGN2) delivery, iNeuron culture and transfection, and the acquisition and analysis of time-lapse images.

View Article and Find Full Text PDF

Engineered Cellular Therapies for the Treatment of Thoracic Cancers.

Cancers (Basel)

December 2024

Division of Hematology, Oncology, and Transplantation, Department of Medicine, University of Minnesota Medical School, Minneapolis, MN 55455, USA.

Thoracic malignancies (lung cancers and malignant pleural mesothelioma) are prevalent worldwide and are associated with high morbidity and mortality. Effective treatments are needed for patients with advanced disease. Cell therapies are a promising approach to the treatment of advanced cancers that make use of immune effector cells that have the ability to mediate antitumor immune responses.

View Article and Find Full Text PDF

Somatic cells can be reprogrammed into pluripotent stem cells (iPSCs) by overexpressing defined transcription factors. Specifically, overexpression of OCT4 alone has been demonstrated to reprogram mouse fibroblasts into iPSCs. However, it remains unclear whether any other single factor can induce iPSCs formation.

View Article and Find Full Text PDF

Human colon organoid differentiation from induced pluripotent stem cells using an improved method.

FEBS Lett

December 2024

Nutri-Life Science Laboratory, Department of Applied Biological Chemistry, Graduate School of Agricultural and Life Sciences, The University of Tokyo, Japan.

The colonic epithelium plays a crucial role in gastrointestinal homeostasis, and colon organoids enable investigation into the molecular mechanisms underlying colonic physiology. However, the method for differentiating induced pluripotent stem cells (iPSCs) into human colon organoids (HCOs) is not necessarily standardized, and studies using HCOs are limited. This study refines the differentiation of HCOs by comparing two protocols reported in Cell Stem Cell and Nature Medicine journals.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!